Kirkland & Ellis LLP should no longer represent Teva Pharmaceutical Industries Ltd. in its hostile bid for Mylan NV, a federal magistrate ruled June 9 (Mylan Inc. v Kirkland & Ellis LLP, W.D. Pa., 2:15- cv-00581, 6/9/15).
In a report and recommendation, U.S. Magistrate Judge Lisa Pupo Lenihan said Kirkland’s past work for Mylan—despite a retainer agreement that seemed to anticipate the potential for future representation of a competitor—should disqualify the firm.
“We strongly disagree with the recommendation made by the magistrate judge, and we reject any suggestion that Kirkland & Ellis’s representation of Teva in its ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.